首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Traditional Chinese Medicine Yimucao Injection Combined with Western Medicine for Preventing Postpartum Hemorrhage after Cesarean Section: A Systematic Review and Meta-Analysis
【24h】

Traditional Chinese Medicine Yimucao Injection Combined with Western Medicine for Preventing Postpartum Hemorrhage after Cesarean Section: A Systematic Review and Meta-Analysis

机译:中药菌注射联合西医治疗后剖宫产后产后出血:系统审查和荟萃分析

获取原文
       

摘要

Objective. Yimucao injection combined with several contraction uterus drugs is in use for preventing postpartum hemorrhage after cesarean section. The present study is a meta-analysis comparing the efficacy and safety of these drugs. Methods. PubMed, Cochrane Library, Embase, the China National Knowledge Infrastructure (CNKI), the Chinese Biomedical Database (CBM), VIP, and Wanfang database were searched until June 2018. We selected RCTs of Yimucao injection combined with western medicine for preventing postpartum hemorrhage and study quality was assessed using the revised Cochrane risk of bias tool. Forty-eight RCTs are comprised of 7,330 participants. Results. The overall response rate of Yimucao injection combined with western medicine as a class (OR=4.19, 95%CI=2.83, 6.20, P0.00001) was found to be significantly improved than western medicine alone. Yimucao injection combined with western medicine group could significantly reduce blood loss in intraoperative (SMD= -1.15, 95%CI= -1.43, -0.87, P0.00001), compared with control group. The treatment group could significantly reduce postpartum blood loss within 2 hours (SMD= -1.73, 95%CI= -2.01, -1.46, P0.00001) and had a significantly lower blood loss within 24 hours (SMD= -1.92, 95%CI= -2.21, -1.63, P0.00001) than control group. Additionally, in terms of the safety, Yimucao injection group reduced the risk of adverse events in the course of prevention than the western medicine group. Conclusions. This study demonstrated that Yimucao injection combined with western medicine may be more effective for preventing postpartum hemorrhage after cesarean section. However, high-quality and large multicenter randomized clinical trials will be needed to prove the consequence in the further.
机译:客观的。 Yimucao注射结合几种收缩子药物用于预防剖宫产后的产后出血。本研究是比较这些药物的疗效和安全性的荟萃分析。方法。 PubMed,Cochrane图书馆,Embase,中国国家知识基础设施(CNKI),中国生物医学数据库(CBM),VIP和WANFANG数据库进行了搜索到2018年6月。我们选择了Yimucao注射液的RCT与西医结合预防产后出血和使用经修订的Cochrane风险评估了研究质量。 48名RCT由7,330名参与者组成。结果。尤卡苏注射的总反应率与西医结合为类别(或= 4.19,95%CI = 2.83,6.20,P <0.00001),仅仅比西医单独改善。与对照组相比,Yimucao注射与西药组联合西医结合术中的血液损失(SMD = -1.15,95%CI = -1.43,-0.87,P <0.00001)。治疗组可以在2小时内显着减少产后失血(SMD = -1.73,95%CI = -2.01,-1.46,P <0.00001),并在24小时内显着降低血液损失(SMD = -1.92,95% CI = -2.21,-1.63,P <0.000000)比对照组。此外,在安全性方面,尤卡苏岛注射组在预防过程中降低了不良事件的风险,而不是西医结合。结论。本研究表明,银泡注射与西药相结合可能对剖宫产后预防产后出血可能更有效。然而,需要高质量和大型多中心随机临床试验,以便进一步证明后果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号